Free Trial
OTCMKTS:CAPS

Capstone (CAPS) Stock Price, News & Analysis

Capstone logo
$2.50 0.00 (0.00%)
As of 02/21/2025

About Capstone Stock (OTCMKTS:CAPS)

Key Stats

Today's Range
$2.50
$2.50
50-Day Range
$2.24
$3.40
52-Week Range
$2.24
$16.18
Volume
1 shs
Average Volume
20 shs
Market Capitalization
$395,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC.

Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone and its competitors with MarketBeat's FREE daily newsletter.

CAPS Stock News Headlines

Signature Picks Up Sci-Fi Thriller ‘Flight 298'
Signature Picks Up Sci-Fi Thriller ‘Flight 298’
Elon “obliterates” Bill Gates?
All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them
See More Headlines

CAPS Stock Analysis - Frequently Asked Questions

Capstone's stock was trading at $2.24 at the start of the year. Since then, CAPS shares have increased by 11.6% and is now trading at $2.50.
View the best growth stocks for 2025 here
.

Capstone Holding Corp. (OTCMKTS:CAPS) announced its quarterly earnings results on Monday, August, 13th. The biotechnology company reported $0.02 EPS for the quarter. The biotechnology company had revenue of $2 million for the quarter.

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Capstone investors own include Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), PlayAGS (AGS), Astronics (ATRO) and CONSOL Coal Resources (CCR).

Company Calendar

Last Earnings
8/13/2018
Today
2/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CAPS
Employees
46
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
90,000
Market Cap
$395,000.00
Optionable
Not Optionable
Beta
-0.65

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (OTCMKTS:CAPS) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners